Bicara Therapeutics Inc (BCAX)

Feb 11, 2026

FMR LLC's Strategic Acquisition of Bicara Therapeutics Inc Shares - GuruFocus

Feb 11, 2026

Feb 05, 2026

Bicara Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

Feb 05, 2026

Feb 04, 2026

Published on: 2026-02-04 16:21:43 - baoquankhu1.vn

Feb 04, 2026

Feb 01, 2026

Aug Technicals: Why is Bicara Therapeutics Inc stock going downTrade Risk Assessment & Fast Entry Momentum Alerts - baoquankhu1.vn

Feb 01, 2026

Jan 31, 2026

Aug Breakouts: Why is Bicara Therapeutics Inc stock going downWeekly Investment Report & Consistent Growth Stock Picks - baoquankhu1.vn

Jan 31, 2026

Jan 30, 2026

Bicara Therapeutics Inc. (NASDAQ:BCAX) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat

Jan 30, 2026

Jan 29, 2026

Citizens Initiates Coverage of Bicara Therapeutics (BCAX) with Market Outperform Recommendation - Nasdaq

Jan 29, 2026

Jan 29, 2026

Bicara Therapeutics (NASDAQ:BCAX) Now Covered by Citizens Jmp - MarketBeat

Jan 29, 2026

Jan 29, 2026

Citizens initiates coverage on Bicara Therapeutics stock with Market Outperform rating By Investing.com - Investing.com Nigeria

Jan 29, 2026

Jan 29, 2026

Citizens initiates coverage on Bicara Therapeutics stock with Market Outperform rating - Investing.com Canada

Jan 29, 2026

Jan 28, 2026

Ivan Hyep Sells 1,882 Shares of Bicara Therapeutics (NASDAQ:BCAX) Stock - Defense World

Jan 28, 2026

Jan 26, 2026

Hyep Ivan, CFO of Bicara Therapeutics, sells $34,162 in BCAX stock - Investing.com Canada

Jan 26, 2026

Jan 26, 2026

Ryan Cohlhepp Sells 3,828 Shares of Bicara Therapeutics (NASDAQ:BCAX) Stock - MarketBeat

Jan 26, 2026

Jan 26, 2026

Stocks showing improving market leadership: Bicara Therapeutics earns 82 RS rating - MSN

Jan 26, 2026

Jan 26, 2026

Bicara Therapeutics (NASDAQ:BCAX) CFO Sells 1,882 Shares - MarketBeat

Jan 26, 2026

Jan 23, 2026

Bicara Therapeutics (BCAX) Investor Outlook: A 74.97% Potential Upside in the Biotech Sector - DirectorsTalk Interviews

Jan 23, 2026

Jan 21, 2026

Analyst Upgrade: Should I set a stop loss on Bicara Therapeutics IncOptions Play & High Accuracy Swing Entry Alerts - baoquankhu1.vn

Jan 21, 2026

Jan 20, 2026

Stocks To Watch: Bicara Therapeutics Sees Relative Strength Rating Rise To 81 - Investor's Business Daily

Jan 20, 2026

Jan 18, 2026

Quarterly Earnings: What are analysts price targets for Bicara Therapeutics IncVolume Spike & Real-Time Buy Signal Alerts - baoquankhu1.vn

Jan 18, 2026

Jan 16, 2026

BCAX: De-Risked FORTIFI-HN01 Path, Differentiated Ficera Profile, and Solid Cash Runway Underpin Buy Rating and $28 Target - TipRanks

Jan 16, 2026

Jan 16, 2026

Bicara Therapeutics Inc. (BCAX) Investor Outlook: Exploring an 84% Potential Upside in Biotechnology - DirectorsTalk Interviews

Jan 16, 2026

Jan 15, 2026

Bicara Therapeutics stock maintains Buy rating at BTIG on clinical progress - Investing.com Nigeria

Jan 15, 2026

Jan 15, 2026

Analysts Have Conflicting Sentiments on These Healthcare Companies: Bicara Therapeutics Inc. (BCAX), NewAmsterdam Pharma Company (NAMS) and GE Healthcare Technologies Inc (GEHC) - The Globe and Mail

Jan 15, 2026

Jan 15, 2026

Does Bicara Therapeutics Inc align with a passive investing strategyDividend Hike & Weekly Market Pulse Updates - baoquankhu1.vn

Jan 15, 2026

Jan 14, 2026

H.C. Wainwright reiterates Buy rating on Bicara Therapeutics stock By Investing.com - Investing.com Nigeria

Jan 14, 2026

Jan 14, 2026

H.C. Wainwright reiterates Buy rating on Bicara Therapeutics stock - Investing.com

Jan 14, 2026

Jan 14, 2026

How cyclical is Bicara Therapeutics Inc.’s revenue stream2025 Market Outlook & Daily Growth Stock Investment Tips - Bollywood Helpline

Jan 14, 2026

Jan 14, 2026

Bicara Therapeutics (NASDAQ:BCAX) Given Outperform Rating at Wedbush - Defense World

Jan 14, 2026

Jan 13, 2026

Growth Report: Will Bicara Therapeutics Inc. stock continue upward momentumJuly 2025 Opening Moves & Weekly Breakout Watchlists - Bộ Nội Vụ

Jan 13, 2026

Jan 13, 2026

Wedbush Reaffirms Outperform Rating for Bicara Therapeutics (NASDAQ:BCAX) - MarketBeat

Jan 13, 2026

Jan 13, 2026

Bicara selects optimal dose for head and neck cancer drug in pivotal study - Investing.com Nigeria

Jan 13, 2026

Jan 13, 2026

Bicara Therapeutics Touts Breakthrough Ficerafusp Data, Picks 1,500 mg Dose for FORTIFY-HNS Trial - MarketBeat

Jan 13, 2026

Jan 12, 2026

Bicara Therapeutics (NASDAQ:BCAX) Shares Down 7%Time to Sell? - MarketBeat

Jan 12, 2026

Jan 12, 2026

BCAX: Ficerafusp alfa shows deep, durable responses and blockbuster potential in head and neck cancer - TradingView

Jan 12, 2026

Jan 12, 2026

Bicara Therapeutics Announces Phase 3 Optimal Dose and Provides 2026 Corporate Outlook - Sahm

Jan 12, 2026

Jan 12, 2026

Bicara Sets Phase 3 Path for Ficerafusp Alfa - TipRanks

Jan 12, 2026

Jan 12, 2026

Bicara Therapeutics announces phase 3 optimal dose and provides 2026 corporate outlook - marketscreener.com

Jan 12, 2026

Jan 12, 2026

Bicara Therapeutics Inc Announces Phase 3 Optimal Dose and 2026 Outlook - TradingView

Jan 12, 2026

Jan 12, 2026

Bicara Therapeutics Announces Phase 3 Optimal Dose And Provides 2026 Corporate Outlook - TradingView

Jan 12, 2026

Jan 11, 2026

Published on: 2026-01-12 06:24:33 - moha.gov.vn

Jan 11, 2026

Jan 11, 2026

Bicara Therapeutics (NASDAQ:BCAX) Trading 7.8% Higher – Should You Buy? - Defense World

Jan 11, 2026

Jan 10, 2026

Is Bicara Therapeutics Inc. stock trading at a premium valuationWeekly Trade Review & Precise Trade Entry Recommendations - ulpravda.ru

Jan 10, 2026

Jan 10, 2026

BTIG Research Begins Coverage on Bicara Therapeutics (NASDAQ:BCAX) - Defense World

Jan 10, 2026

Jan 09, 2026

Bicara Therapeutics Inc.Common Stock (NQ: BCAX - FinancialContent

Jan 09, 2026

Jan 09, 2026

Bicara Therapeutics (NASDAQ:BCAX) Trading Up 7.8%Here's Why - MarketBeat

Jan 09, 2026

Jan 09, 2026

Bicara Therapeutics (NASDAQ:BCAX) Upgraded to "Strong-Buy" at BTIG Research - MarketBeat

Jan 09, 2026

Jan 09, 2026

Published on: 2026-01-09 02:43:58 - Улправда

Jan 09, 2026

Jan 09, 2026

Is Bicara Therapeutics Inc. stock a defensive play in 2025July 2025 Breakouts & Safe Entry Trade Signal Reports - Улправда

Jan 09, 2026